Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02390245 · ClinicalTrials.gov registry record · NA
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 906
- Enrollment target
NCT02390245: Completed NA study, sponsored by Wills Eye.
NCT02390245 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 906 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02390245, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 906 participants
- Enrollment target
Study Summary
The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.
Primary Outcome
Phase I. Detection of glaucoma and other eye diseases using non contact, autofocus, hand-held fundus camera (Volk Optical, Mentor, Ohio, USA) with images of optic nerve and macula and confirmed at follow-up full dilated eye examination by ophthalmologists.
Interventions
- OTHER Usual Care
- OTHER Enhanced Intervention
- OTHER Free Eye Screenings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 906 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-08 |
| Phase | NA |
What the finished NCT02390245 record still lists
NCT02390245 is an interventional study that assigns participants to a tested intervention. The registered 906 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT02390245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02390245 about?
NCT02390245 is a clinical study titled "Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study". The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect...
What is the current status of trial NCT02390245?
This trial is currently completed. It is a NA study. The enrollment target is 906 participants. The study started on 2014-09. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02390245?
The interventions under investigation include: Usual Care (OTHER), Enhanced Intervention (OTHER), Free Eye Screenings (OTHER).
Who is sponsoring clinical trial NCT02390245?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02390245's enrollment target sits among peer trials
906 124th of 2000 higher than 1,877 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia